Health & Life Co., Ltd.

TWO:1781 Taiwan Medical Devices
Market Cap
$17.70 Million
NT$585.48 Million TWD
Market Cap Rank
#27387 Global
#1738 in Taiwan
Share Price
NT$12.35
Change (1 day)
-0.40%
52-Week Range
NT$10.95 - NT$15.50
All Time High
NT$15.50
About

Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.

Health & Life Co., Ltd. - Asset Resilience Ratio

Latest as of September 2025: 0.04%

Health & Life Co., Ltd. (1781) has an Asset Resilience Ratio of 0.04% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$290.00K
Cash + Short-term Investments
Total Assets
NT$656.14 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Health & Life Co., Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Health & Life Co., Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$290.00K 0.04%
Total Liquid Assets NT$290.00K 0.04%

Asset Resilience Insights

  • Limited Liquidity: Health & Life Co., Ltd. maintains only 0.04% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Health & Life Co., Ltd. Industry Peers by Asset Resilience Ratio

Compare Health & Life Co., Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Health & Life Co., Ltd. (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Health & Life Co., Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 6.16% NT$50.32 Million NT$817.26 Million +6.11pp
2023-12-31 0.05% NT$327.00K NT$710.79 Million +0.00pp
2022-12-31 0.04% NT$343.00K NT$799.76 Million +0.00pp
2021-12-31 0.04% NT$303.00K NT$776.39 Million --
pp = percentage points